CIBC World Market
ALNY icon

CIBC World Market’s Alnylam Pharmaceuticals ALNY Stock Holding History

CIBC World Market’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Buy
+7,221
New +$2.18M ﹤0.01% 824
2026
Q1 		– Sell
-12,225
Closed -$4.86M – 1470
2025
Q4 		$4.86M Buy
12,225
+109
+0.9% +$48.2K 0.01% 576
2025
Q3 		$5.52M Buy
+12,116
New +$4.93M 0.01% 555

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC World Market's ALNY Position: Q2 2026 in Review

CIBC World Market opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 7,221 shares worth $2.17M. The stake represents ﹤0.01% of the portfolio and ranks #824 among its holdings. This is a return to the name: CIBC World Market previously reported a position in ALNY as recently as Q4 2025.

CIBC World Market first reported a position in ALNY in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.52M in Q3 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • CIBC World Market held 7,221 shares of Alnylam Pharmaceuticals worth $2.17M as of Q2 2026.
  • Alnylam Pharmaceuticals was a new CIBC World Market position in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #824 holding.
  • CIBC World Market first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • CIBC World Market's Alnylam Pharmaceuticals position peaked at $5.52M in Q3 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.